← Back to Search

Procedure

Ablation for Atrial Flutter

N/A
Recruiting
Led By Aneesh Tolat, MD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at one month after ablation
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate the safety, feasibility, and efficacy of performing atrial flutter ablation through the arm vs. the standard femoral vein approach. #MedicalStudy #AtrialFlutter

Who is the study for?
This trial is for outpatients weighing at least 50 kg with documented typical atrial flutter, referred for right atrial flutter ablation. It's not open to inpatients, those unable to consent, individuals under 50 kg, or patients with a pacemaker or defibrillator with transvenous leads.
What is being tested?
The study tests the safety and effectiveness of performing atrial flutter ablation through the arm instead of the femoral vein. It compares recovery time, success rates of maintaining sinus rhythm without recurrence, complication rates including bleeding and heart issues, and pain severity at insertion sites between both methods.
What are the potential side effects?
Potential side effects include complications from accessing veins such as bleeding or thrombosis (clotting), heart perforation during the procedure, discomfort at the site where catheters are inserted into the body (either arm or groin), and possible failure to maintain normal heart rhythm post-procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at one month after ablation
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at one month after ablation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Recovery time
Secondary study objectives
Complication rate
Frequency of complications
One month success rate
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ablation through upper extremityExperimental Treatment1 Intervention
Ablation through arm
Group II: Ablation through femoral veinActive Control1 Intervention
Ablation through vein

Find a Location

Who is running the clinical trial?

Hartford HospitalLead Sponsor
139 Previous Clinical Trials
19,653 Total Patients Enrolled
Aneesh Tolat, MDPrincipal InvestigatorHartford Hospital
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Ablation through femoral vein (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05755074 — N/A
Atrial Flutter Research Study Groups: Ablation through upper extremity, Ablation through femoral vein
Atrial Flutter Clinical Trial 2023: Ablation through femoral vein Highlights & Side Effects. Trial Name: NCT05755074 — N/A
Ablation through femoral vein (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755074 — N/A
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top